143 related articles for article (PubMed ID: 38413076)
21. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
Xiao JW; Liu ZL; Ye PC; Luo YJ; Fu ZM; Zou Q; Wei SJ
World J Gastroenterol; 2015 Sep; 21(34):9999-10007. PubMed ID: 26379405
[TBL] [Abstract][Full Text] [Related]
22. Treatment of esophagogastric junction carcinoma: an unsolved debate.
Orditura M; Galizia G; Lieto E; De Vita F; Ciardiello F
World J Gastroenterol; 2015 Apr; 21(15):4427-31. PubMed ID: 25914451
[TBL] [Abstract][Full Text] [Related]
23. Surgical management of esophagogastric junction tumors.
von Rahden BH; Stein HJ; Siewert JR
World J Gastroenterol; 2006 Nov; 12(41):6608-13. PubMed ID: 17075972
[TBL] [Abstract][Full Text] [Related]
24. [Cancer of the Esophagogastric Junction: Double Tract Reconstruction - Evidence and Technique].
Berlth F; Fetzner UK; Mihaljevic AL; Grimminger P
Zentralbl Chir; 2024 Apr; 149(2):202-208. PubMed ID: 38565166
[TBL] [Abstract][Full Text] [Related]
25. Comparison of three digestive tract reconstruction methods for the treatment of Siewert II and III adenocarcinoma of esophagogastric junction: a prospective, randomized controlled study.
Li Z; Dong J; Huang Q; Zhang W; Tao K
World J Surg Oncol; 2019 Dec; 17(1):209. PubMed ID: 31810484
[TBL] [Abstract][Full Text] [Related]
26. [Dilemmas in definition and classification of adenocarcinoma of esophagogastric junction: from history to current status].
Chen L; Liu FL
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):813-818. PubMed ID: 36058706
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
[TBL] [Abstract][Full Text] [Related]
28. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
29. [Treatment Strategy for Esophagogastric Junction Carcinoma;Highly Controversial Topic in the Upper Gastrointestinal Malignancy].
Yamashita H; Seto Y
Kyobu Geka; 2017 Jan; 70(1):72-79. PubMed ID: 28174399
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
31. [Minimally invasive surgery in adenocarcinoma of esophagogastric junction].
Zang L; Li S; Zheng M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):875-880. PubMed ID: 30136267
[TBL] [Abstract][Full Text] [Related]
32. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
33. [Advantages and disadvantages of transthoracic approach for adenocarcinoma of the esophagogastric junction].
Tan LJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):147-150. PubMed ID: 35176827
[TBL] [Abstract][Full Text] [Related]
34. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
Lee IS; Ahn JY; Yook JH; Kim BS
World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
[TBL] [Abstract][Full Text] [Related]
35. [A Case of Advanced Adenocarcinoma at the Esophagogastric Junction That Exhibited pCR by Preoperative SOX Therapy].
Mihara D; Kuwada K; Hamazaki T; Namba K; Takahashi T; Takehara K; Kuise T; Kuroda M; Yamano T; Takagi S; Ikeda E; Kemmotsu M; Ikeda T
Gan To Kagaku Ryoho; 2022 Jun; 49(6):693-696. PubMed ID: 35799398
[TBL] [Abstract][Full Text] [Related]
36. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
37. [Clinical outcomes of surgical patients with types II and III adenocarcinoma of esophagogastric junction].
Chen XF; Chen HN; Zhang B; Chen ZX; Hu JK; Wang F; Yang HX; Chen JP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):289-92. PubMed ID: 22650050
[TBL] [Abstract][Full Text] [Related]
38. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
[TBL] [Abstract][Full Text] [Related]
39. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
[TBL] [Abstract][Full Text] [Related]
40. Ongoing Controversies in Esophageal Cancer II: Gastrectomy versus Esophagectomy for Siewert Type II Esophageal Adenocarcinoma.
Devaud N; Carroll P
Thorac Surg Clin; 2022 Nov; 32(4):553-563. PubMed ID: 36266040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
